Prognostic Significance of the Peripheral Blood Absolute Monocyte Count in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma Receiving Systemic Chemotherapy |
Lin, Gui-Nan
(Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital)
Jiang, Xiao-Mei (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) Peng, Jie-Wen (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) Xiao, Jian-Jun (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) Liu, Dong-Ying (Department of Clinical Oncology, Jiangmen Hospital of Sun Yat-sen University, Jiangmen City Central Hospital) Xia, Zhong-Jun (State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center) |
1 | Sasaki A, Iwashita Y, Shibata K, et al (2006). Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery, 139, 755-64. DOI |
2 | Schimanski CC, Bahre R, Gockel I, et al (2006). Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer, 95, 210-7. DOI ScienceOn |
3 | Takai H, Kato A, Kato C, et al (2009). The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma. Liver Int, 29, 1056-64. DOI |
4 | Wang Z, Wu XL, Zeng WZ et al (2013). Meta-analysis of the efficacy of sorafenib for hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 691-4. 과학기술학회마을 DOI ScienceOn |
5 | Werno C, Menrad H, Weigert A, et al (2010). Knockout of HIF- in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis, 31, 1863-72. DOI |
6 | Yang HI, Lu SN, Liaw YF, et al (2002). Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med, 347, 168-74. DOI ScienceOn |
7 | Yang Y, Nagano H, Ota H, et al (2007). Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery, 141, 196-202. DOI ScienceOn |
8 | Yu Q, Yu XF, Zhang SD, et al (2013). Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 5735-40. 과학기술학회마을 DOI ScienceOn |
9 | Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. 과학기술학회마을 DOI ScienceOn |
10 | Zhu XD, Zhang JB, Zhuang PY, et al (2008). High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol, 26, 2707-16. DOI ScienceOn |
11 | Benetti A, Berenzi A, Gambarotti M, et al (2008). Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res, 68, 8626-34. DOI |
12 | Castello G, Scala S, Palmieri G, et al (2010). HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clin Immunol, 134, 237-50. DOI |
13 | Chen J, Li G, Meng H, et al (2012). Up regulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas. Cancer Immunol Immunother, 61, 101-8. DOI |
14 | Cheng AL, Kang YK, Chen Z, et al (2009). Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, doubleblind, placebo-controlled trial. Lancet Oncol, 10, 25-34. DOI ScienceOn |
15 | Cui L, Liu XX, Jiang Y, et al (2012). Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients. Asian Pac J Cancer Prev,13, 6257-61. DOI ScienceOn |
16 | Dai J, Tang K, Xiao W, et al (2014). Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3369-75. 과학기술학회마을 DOI |
17 | Farazi PA and DePinho RA (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 6, 674-87. DOI ScienceOn |
18 | Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma-current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. 과학기술학회마을 DOI ScienceOn |
19 | Gomaa AI, Hashim MS, Waked I (2014). Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt. PLoS One, 9, e90929. DOI |
20 | He SL, Shen J, Sun XJ, et al (2013). Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments. World J Gastroenterol, 19, 4552-8. DOI |
21 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
22 | Kuang DM, Peng C, Zhao Q, et al (2010). Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol, 185, 1544-9. DOI |
23 | Lee YY, Choi CH, Sung CO, et al (2012). Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol, 124, 92-7. DOI |
24 | Li J, Jiang R, Liu WS, et al (2013). A large cohort study reveals the association of elevated peripheral blood lymphocyte-tomonocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One, 8, e83069. DOI |
25 | Liu H, Pan Z, Li A, et al (2008). Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol, 5, 373-8. DOI |
26 | Lok AS, Seeff LB, Morgan TR, et al (2009). Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology, 136, 138-48. DOI ScienceOn |
27 | Louafi S, Boige V, Ducreux M, et al (2007). Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study. Cancer, 109, 1384-90. DOI |
28 | Ma WJ, Wang HY and Teng LS (2013). Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Oncol, 11, 212. DOI |
29 | Ma TC, Shao HB, Xu Y, et al (2013). Three treatment methods via the hepatic artery for hepatocellular carcinoma-a retrospective study. Asian Pac J Cancer Prev, 14, 2491-4. 과학기술학회마을 DOI ScienceOn |
30 | Norsa'adah B, Nurhazalini-Zayani CG (2013). Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia. Asian Pac J Cancer Prev, 14, 6955-9. 과학기술학회마을 DOI ScienceOn |
31 | Peng SH, Deng H, Yang JF, et al (2005). Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol, 11, 6521-4. |
32 | Qin S, Bai Y, Lim HY, et al (2013). Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol, 31, 3501-8. DOI ScienceOn |
33 | Huang JJ, Li YJ, Xia Y, et al (2013). Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma. BMC Cancer, 13, 222. DOI |